European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

被引:71
作者
Panzuto, Francesco [1 ,11 ]
Ramage, John [2 ,3 ]
Pritchard, D. Mark [4 ]
van Velthuysen, Marie-Louise F. [5 ]
Schrader, Joerg [6 ]
Begum, Nehara [7 ]
Sundin, Anders [8 ]
Falconi, Massimo [9 ]
O'Toole, Dermot [10 ]
机构
[1] Sapienza Univ Rome, St Andrea Univ Hosp, ENETS Ctr Excellence, Dept Med Surg Sci & Translat Med,Digest Dis Unit, Rome, Italy
[2] Hampshire Hosp, Dept Gastroenterol, Kings Hlth Partners London, London, England
[3] ENETS Ctr, Kings Hlth Partners London, London, England
[4] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, England
[5] Erasmus MC, Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands
[6] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany
[7] Ruhr Univ Bochum, Univ Hosp, Dept Gen Visceral Thorac & Endocrine Surg, Johannes Wesling Klinikum Minden, Bochum, Germany
[8] Uppsala Univ, Dept Surg Sci Radiol & Mol Imaging, Uppsala, Sweden
[9] IRCCS San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, Pancreat Surg Unit, Milan, Italy
[10] St Vincents Univ Hosp, Natl Ctr Neuroendocrine Tumours, ENETS Ctr Excellence, Dublin, Ireland
[11] Sapienza Univ Rome, ENETS Ctr Excellence, Dept Med Surg Sci & Translat Med, Digest Dis Unit,St Andrea Univ Hosp, Via Grottarossa 1035, I-00189 Rome, Italy
关键词
duodenal neuroendocrine tumours; gastric carcinoids; guidelines; management; prognosis; AMPULLARY CARCINOID-TUMORS; ZOLLINGER-ELLISON SYNDROME; ENDOSCOPIC SURVEILLANCE; CONSENSUS GUIDELINES; PROGNOSTIC-FACTORS; MANAGEMENT; DIAGNOSIS; SURVIVAL; FEATURES; DISEASE;
D O I
10.1111/jne.13306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.
引用
收藏
页数:14
相关论文
共 65 条
[1]   ZOLLINGER-ELLISON SYNDROME CAN BE THE INITIAL ENDOCRINE MANIFESTATION IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA-TYPE-I [J].
BENYA, RV ;
METZ, DC ;
VENZON, DJ ;
FISHBEYN, VA ;
STRADER, DB ;
ORBUCH, M ;
JENSEN, RT .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (05) :436-444
[2]   ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors [J].
Borbath, Ivan ;
Pape, Ulrich-Frank ;
Deprez, Pierre H. ;
Bartsch, Detlef Klaus ;
Caplin, Martyn ;
Falconi, Massimo ;
Garcia-Carbonero, Rocio ;
Grozinsky-Glasberg, Simona ;
Jensen, Robert T. ;
Arnold, Rudolf ;
Ruszniewski, Philippe ;
Toumpanakis, C. ;
Valle, Juan W. ;
Toole, Dermot O. .
JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (03)
[3]   Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis [J].
Boyce, Malcolm ;
Moore, Andrew R. ;
Sagatun, Liv ;
Parsons, Bryony N. ;
Varro, Andrea ;
Campbell, Fiona ;
Fossmark, Reidar ;
Waldum, Helge L. ;
Pritchard, D. Mark .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (03) :466-475
[4]   Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme [J].
Chin, Jun Liong ;
O'Connell, Jim ;
Muldoon, Cian ;
Swan, Niall ;
Reynolds, John Vincent ;
Ravi, Narayanasamy ;
Geoghegan, Justin ;
Conlon, Kevin C. ;
O'Shea, Donal ;
O'Toole, Dermot .
DIGESTIVE SURGERY, 2021, 38 (01) :38-45
[5]  
Chin JL, 2017, CLIN ENDOSC, V50, P520, DOI 10.5946/ce.2017.181
[6]   Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment A Digestive Endoscopy Society of Tawian (DEST) [J].
Chung, Chen-Shuan ;
Tsai, Cho-Lun ;
Chu, Yin-Yi ;
Chen, Kuan-Chih ;
Lin, Jung-Chun ;
Chen, Bao-Chung ;
Sun, Wei-Chih ;
Yen, Hsu-Heng ;
Chen, Chiung-Yu ;
Wu, I-Chen ;
Kuo, Chao-Hung ;
Shih, Hisang-Yao ;
Bair, Ming-Jong ;
Wang, Jack P. ;
Hu, Wen-Hao ;
Yang, Chang-Shyue ;
Han, Ming-Lun ;
Cheng, Tsu-Yao ;
Tseng, Chao-Ming ;
Tsai, Ming-Chang ;
Hu, Ming-Luen ;
Wang, Hsiu-Po .
MEDICINE, 2018, 97 (38)
[7]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[8]   Treatment outcomes of advanced digestive well-differentiated grade 3 NETs [J].
de Mestier, Louis ;
Lamarca, Angela ;
Hernando, Jorge ;
Zandee, Wouter ;
Alonso-Gordoa, Teresa ;
Perrier, Marine ;
Walenkamp, Annemiek M. E. ;
Chakrabarty, Bipasha ;
Landolfi, Stefania ;
Van Velthuysen, Marie-Louise F. ;
Kats-Ugurlu, Gursah ;
Caminoa, Alejandra ;
Ronot, Maxime ;
Manoharan, Prakash ;
Garcia-Alvarez, Alejandro ;
Brabander, Tessa ;
Garcia Gomez-Muriel, Maria Isabel ;
Cadiot, Guillaume ;
Couvelard, Anne ;
Capdevila, Jaume ;
Pavel, Marianne E. ;
Cros, Jerome .
ENDOCRINE-RELATED CANCER, 2021, 28 (08) :549-561
[9]   ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms [J].
Delle Fave, Gianfranco ;
Kwekkeboom, Dik J. ;
Van Cutsem, Erik ;
Rindi, Guido ;
Kos-Kudla, Beata ;
Knigge, Ulrich ;
Sasano, Hironobu ;
Tomassetti, Paola ;
Salazar, Ramon ;
Ruszniewski, Philippe .
NEUROENDOCRINOLOGY, 2012, 95 (02) :74-87
[10]   Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy [J].
Dogeas, Epameinondas ;
Cameron, John L. ;
Wolfgang, Cristopher L. ;
Hirose, Kenzo ;
Hruban, Ralph H. ;
Makary, Martin A. ;
Pawlik, Timothy A. ;
Choti, Michael A. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (08) :1262-1269